Core Insights - The announcement of The Top 50 Women Chief Growth Officers for 2025 highlights the growing importance of the Chief Growth Officer role in shaping business strategy and driving sustainable growth [1][5] Group 1: Recognition of Leaders - Jasmin Valdez, Chief Growth Officer of ProHealth Home Care, is recognized for her extensive experience in healthcare and her role in improving market position and managing marketing activities [2] - Amy Katz, Chief Growth Officer at PACE Southeast Michigan, is acknowledged for her leadership in business development and program expansion, enhancing community-based care for seniors [3] - Amanda Custodio, Chief Growth Officer of BMO Wealth Management, is celebrated for providing strategic direction for growth initiatives across various financial services [4] Group 2: Broader Impact - The initiative aims to celebrate the accomplishments of women leaders in executive roles, inspiring others to pursue leadership positions [5][7] - Women We Admire circulates content to over 70,000 individuals and businesses, emphasizing the recognition of exceptional women across various fields [7]

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce that Chris Dobbin, President & CEO of Nova Leap, will present at the upcoming Planet MicroCap Showcase, in partnership with MicroCapClub, on October 22–23, 2025. The presentation will highlight Nova Leap’s record second-quarter financi ...

Core Insights - The Pennant Group, Inc. has acquired certain operations from UnitedHealth Group for $146.5 million, which includes home health, hospice, and personal care services in Tennessee, Georgia, and Alabama [1][2]. Acquisition Details - The acquisition involves 54 locations with combined revenues of $189.3 million over the trailing twelve months [2]. - Approximately two-thirds of the revenue from the acquired agencies is related to home health services, while one-third is from hospice services [3]. Strategic Importance - This acquisition marks a strategic expansion for Pennant into the Southeast region, enhancing its operational footprint and growth potential [4]. - The company has established a transition services agreement with UnitedHealth to ensure a smooth integration process [3]. Leadership Perspective - Pennant's CEO, Brent Guerisoli, emphasized the strategic nature of this move and the company's commitment to operational excellence and leadership in the industry [4]. - COO John Gochnour highlighted the quality of the acquired teams and their local ties, which will contribute to the success of the integration [4]. Future Growth Plans - The company intends to continue pursuing growth opportunities in the home health, hospice, and senior living sectors, focusing on strategic and underperforming operations [4].

Summary of Enhabit Conference Call Company Overview - Enhabit is a significant operator of home nursing services in the United States, having spun out from Encompass on July 1, 2022, with 249 home health locations and 114 hospice locations across 34 states [4][5] Core Industry Insights - The company is focusing on recruitment and retention post-pandemic, with a shift towards implementing a payer strategy, particularly in Medicare Advantage (MA) [4][6] - Enhabit has been negotiating contracts with Medicare Advantage plans to ensure fair compensation for services, which has been a two-and-a-half-year effort [6][7] Financial Performance and Projections - The company anticipates a potential $35 to $40 million headwind due to proposed cuts from the Centers for Medicare & Medicaid Services (CMS), which includes a significant 9% cut offset by market basket adjustments [7][10] - Enhabit is piloting a strategy to increase visits per episode (VPE), which could yield an annual benefit of $5 million to $8 million for each half visit reduced [13][14] Legislative and Regulatory Environment - There is a proposed legislative bill for a two-year pause on cuts to home health services, citing flawed methodologies and fraudulent data in CMS's proposals [8][9] - The company is preparing for potential disruptions in the industry due to these proposed cuts, focusing on optimizing costs and enhancing growth opportunities in hospice services [11][20] Operational Strategies - Enhabit is enhancing its operational efficiency by focusing on general and administrative (G&A) cost reductions without compromising capability [18][19] - The company is also exploring technology investments to improve clinician efficiency and documentation processes [47][48] Market Position and Competitive Landscape - Enhabit has successfully negotiated contracts with major payers, positioning itself as a full-service provider, which is crucial for maintaining market share [25][27] - The company is experiencing improved cash flows and is considering strategic M&A opportunities in light of potential industry disruptions [21][23] Growth in Hospice Services - Enhabit has seen substantial growth in its hospice platform due to improved care management and business development strategies [48][49] - The company has focused on diversifying referral sources and enhancing response times for patient admissions [49] Future Outlook - The next leadership will have opportunities to leverage technology and innovation to differentiate Enhabit in the market, particularly in attracting more clinicians and increasing market share [53][54] - The company is optimistic about its positioning and growth potential, despite the challenges posed by regulatory changes [54][55]

Core Viewpoint - The Pennant Group, Inc. has acquired a premier home health agency and outpatient therapy operation in Wyoming, expanding its service area and enhancing its ability to provide compassionate care to more residents in the region [1][2]. Group 1: Acquisition Details - The acquisition took effect on September 1, 2025, and the businesses will operate under the names Healing Hearts Home Health and Healing Hearts Outpatient Therapy [1]. - The new operations will serve communities in Gillette and Moorcroft, thereby increasing Pennant's footprint in Wyoming [1]. Group 2: Leadership Insights - CEO Brent Guerisoli emphasized the importance of meeting healthcare needs in the community and expressed confidence that the expansion will allow for more personalized care [2]. - President and COO John Gochnour highlighted that the acquisition is not only about geographical growth but also about making a positive impact on care delivery in Eastern Wyoming [3]. Group 3: Company Overview - The Pennant Group, Inc. operates through independent subsidiaries providing healthcare services across various states, including home health, hospice, and senior living communities [4]. - Each subsidiary operates independently with its own management and assets, ensuring localized care tailored to community needs [4].

Core Viewpoint - Nova Leap Health Corp. reported record financial results for Q2 2025, highlighting significant growth in revenues, gross margins, and Adjusted EBITDA, indicating strong operational performance and effective business strategies [2][4][7]. Financial Performance - Q2 2025 revenues reached $8,021,072, marking a 13.1% increase from Q1 2025 and a 26.5% increase from Q2 2024 [2]. - Adjusted EBITDA for Q2 2025 was $577,907, a 99.9% increase from Q1 2025 and a 41.7% increase from Q2 2024 [4]. - Gross profit margin was 40.2% in Q2 2025, up from 39.0% in Q1 2025 and 38.4% in Q2 2024 [10]. Operational Highlights - The company achieved record consolidated quarterly revenues, gross margins, and Adjusted EBITDA across both Canadian and U.S. operating segments [5]. - The acquisition of a home care business in Nova Scotia for CAD$390,000 was completed in May 2025, contributing to the company's growth [10]. - Insider ownership increased to 42.26%, reflecting management's confidence in the company's future [11]. Strategic Initiatives - The company is focused on building a tech-enabled organization that leverages AI and fintech to enhance productivity [9]. - Operating leverage is evident, with Adjusted EBITDA margin expanding to 7.2% from 4.1% in Q1 2025, showcasing improved returns from scale and operational discipline [8]. Market Position - Nova Leap operates in a rapidly growing home health care industry, with a focus on individual and family-centered care, particularly for dementia patients [12]. - The company is geographically diversified, with operations in 10 U.S. states and Nova Scotia, Canada [12].

Financial Data and Key Metrics Changes - Revenue for Q2 was approximately $590 million, representing a 16.8% increase over the prior year period [5][22] - Adjusted EBITDA for Q2 was $88.3 million, reflecting a 93.6% increase compared to the prior year, primarily due to improved rate environment and cost savings initiatives [5][22] - Consolidated gross margin was $210.8 million or 35.8% [22] Business Line Data and Key Metrics Changes - Private Duty Services revenue was approximately $486 million, a 19.2% increase, driven by a volume increase of 6.9% [23] - Home Health and Hospice revenue for the quarter was approximately $60.1 million, a 10% increase, with 74.5% of admissions being episodic [26] - Medical Solutions revenue was $43.4 million, a 2.2% increase, with gross margins at approximately 45.6% [28] Market Data and Key Metrics Changes - Preferred payer agreements accounted for approximately 55% of total private duty services MCO volumes [11] - The episodic payer mix was 74.5%, with total episodic volume growth of 6.9% compared to the prior year [12] Company Strategy and Development Direction - The company is focusing on enhancing partnerships with government partners and preferred payers to create additional capacity and growth [19] - The strategic plan includes modernizing the Medical Solutions business and managing capital structure while producing positive free cash flow [19] - The company aims to increase the number of private duty service preferred payer agreements from 22 to 30 by the end of 2025 [10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the demand for home and community-based care, indicating that the industry does not have a demand problem [6] - The company anticipates 2025 revenue to exceed $2.3 billion and adjusted EBITDA to exceed $270 million, reflecting a strong outlook despite regulatory challenges [20][34] - Management highlighted the importance of aligning caregiver capacity with preferred payers to improve clinical and financial outcomes [29] Other Important Information - The company has achieved 10 rate enhancements year to date in the private duty services segment [10] - The integration of the Thrive Skilled Pediatrics acquisition is on target and expected to be accretive to 2025 results [15] Q&A Session Summary Question: Can you walk us through the $53 million increase in guidance for EBITDA? - Management indicated that the increase is based on strong rate outlook and improved volume in the PDS business, with good visibility into 2025 [38][40] Question: Are you seeing an increase in the number of caregivers due to wage rate increases? - Management confirmed that there has been a continued uplift in caregiver hiring, with 11 million hours recorded in Q2 for the PDS segment [53][55] Question: How do you characterize HCBS positioning amid broader budgetary headwinds? - Management noted that while rate enhancements have been more muted, the value of home care is recognized by state governors, and they continue to advocate for necessary rate increases [72][74] Question: What is the potential impact of proposed cuts to home health on episodic rates? - Management expressed disappointment in the proposed cuts, emphasizing that such policies are harmful to seniors and rural healthcare, while affirming that Aviana is well-positioned regardless of the outcome [78][82] Question: How much demand remains for getting patients out of hospitals? - Management indicated that there is still significant demand, with many preferred payers seeking more coverage and services from Aviana [88][90]

Financial Data and Key Metrics Changes - Consolidated net service revenue for Q2 2025 was $266.1 million, reflecting a sequential increase of $6.2 million or 2.4% and a year-over-year growth of $5.5 million or 2.1% [21] - Consolidated adjusted EBITDA was $26.9 million, an increase of $300,000 or 0.7% sequentially and $1.7 million or 6.7% year-over-year, with an adjusted EBITDA margin of 10.1%, up 40 basis points from the prior year [21][20] - Adjusted free cash flow year-to-date totaled $27.8 million, representing a 51.9% free cash flow conversion rate [26] Business Line Data and Key Metrics Changes - Home Health revenue was $205.9 million, showing sequential growth of $5.3 million or 2.6%, but down $4.3 million or 2% year-over-year [21] - Home Health adjusted EBITDA totaled $39.3 million, reflecting a sequential increase of $1 million or 2.6% [22] - Hospice revenue reached $60.2 million, with sequential growth of $900,000 or 1.5% and a year-over-year increase of $9.8 million or 19.4% [24] Market Data and Key Metrics Changes - Home Health admissions were up 1.3% year-over-year, with a normalized growth of 2% when accounting for closed branches [10] - Non-Medicare admissions increased by 5.2% year-over-year, primarily within payer innovation contracts [11] - Hospice segment experienced total admissions growth of 8.7% year-over-year, with same-store growth of 5.7% [12] Company Strategy and Development Direction - The company is focused on mitigating the impact of proposed cuts from CMS by evaluating operational levers, including advanced visit per episode management [7][10] - A de novo strategy is being implemented, with plans to open 10 new locations in areas with strong growth potential [13] - The company aims to maintain competitive wage rates to recruit and retain skilled workforce amid a highly competitive labor market [9] Management's Comments on Operating Environment and Future Outlook - Management expressed concerns over CMS's proposed cuts, which could compromise access to home health care services and pressure provider sustainability [16][17] - The company believes it is well-positioned to outperform smaller competitors due to its scalable operating model and investments in technology [18] - Management remains confident in the full-year outlook, updating revenue guidance to a range of $1.06 billion to $1.073 billion [27] Other Important Information - The CEO announced plans to step down in July 2026, emphasizing the need for new leadership to elevate the company [29][30] - The company has successfully reduced overall bank debt by $10.5 million during the quarter [26] Q&A Session Summary Question: How is the company thinking about mitigating the negative impact of the proposed home nursing rule? - Management indicated that various operational levers are being considered, including the advanced PPE initiative, which will be piloted in the coming weeks [34] Question: Can you provide details on the recent payer disruption and its impact? - The company successfully renegotiated a national payer contract, achieving a low double-digit increase in per visit rates, and has since regained a significant portion of the lost census [36][37] Question: What are the longer-term leverage targets before pivoting to M&A or heavier investments? - Management stated that while specific leverage targets have not been provided, the focus remains on deleveraging the balance sheet before considering M&A activities [52] Question: Can you elaborate on the pilot programs and what success will look like? - The pilot programs will focus on operationalizing advanced visit per episode management, with success gauged by the ability to free up capacity and direct it to additional patient loads [62][64]

Core Insights - Extendicare Inc. reported strong financial results for Q2 2025, with significant growth in revenue and adjusted EBITDA, driven by strategic acquisitions and increased demand for services [3][8][15]. Financial Performance - Revenue for Q2 2025 increased by $35.0 million to $383.4 million, representing an 11.4% growth when excluding out-of-period LTC funding from Q2 2024 [15][29]. - Adjusted EBITDA rose by $5.3 million or 15.4% to $39.8 million, reflecting growth in home health care and long-term care segments [8][15]. - Net earnings increased by $6.0 million to $31.9 million, supported by higher adjusted EBITDA and other income [15][30]. Strategic Acquisitions - The company completed the acquisition of Closing the Gap for approximately $75.1 million, expected to add 1.1 million service hours to the home health care segment [3][10]. - The acquisition of nine LTC homes from Revera for $41.3 million was finalized, enhancing the company's long-term care portfolio [6][15]. - The sale of three LTC projects to Axium JV generated net cash proceeds of $56.3 million, resulting in a gain of $11.1 million [4][15]. Operational Highlights - Home health care average daily volume (ADV) increased by 10.9% to 33,310 in Q2 2025 [8][23]. - Long-term care average occupancy rose to 98.3%, up 50 basis points from the previous year [19][20]. - The number of third-party and joint venture beds serviced by SGP reached approximately 149,300, a 5.9% increase from the prior year [24]. Financial Position - As of June 30, 2025, Extendicare had cash and cash equivalents of $72.6 million, with access to an additional $152.2 million under its revolving facility [26]. - The company increased its senior secured credit facility to $375.0 million, enhancing liquidity for future growth [3][8]. Dividend Declaration - The Board of Directors declared a cash dividend of $0.042 per share for August 2025, payable on September 15, 2025 [31].

Core Insights - Extendicare Inc. reported strong financial results for Q2 2025, with significant growth in revenue and adjusted EBITDA, driven by strategic acquisitions and increased demand for services [3][8][14]. Financial Performance - Revenue for Q2 2025 increased by $35.0 million to $383.4 million, representing an 11.4% growth when excluding out-of-period funding from Q2 2024 [14]. - Adjusted EBITDA rose by $5.3 million or 15.4% to $39.8 million, reflecting growth in home health care and improvements in long-term care [8][14]. - Net earnings increased by $6.0 million to $31.9 million, supported by higher adjusted EBITDA and other income [14][21]. Acquisitions and Transactions - The company completed the acquisition of Closing the Gap for approximately $75.1 million, expected to add 1.1 million service hours to the home health care segment [3][9]. - Extendicare acquired nine long-term care homes from Revera for approximately $41.3 million, enhancing its portfolio [6][14]. - The sale of three long-term care projects to Axium JV generated net cash proceeds of $56.3 million, resulting in a gain of $11.1 million [4][14]. Operational Highlights - Home health care average daily volume (ADV) increased to 33,310, a 10.9% rise from Q2 2024 [8][22]. - Long-term care average occupancy improved to 98.3%, up 50 basis points from the previous year [17]. - The number of third-party and joint venture beds serviced by SGP reached approximately 149,300, a 5.9% increase from the prior year [23]. Strategic Initiatives - The Ontario government announced a new capital funding policy for long-term care homes, providing greater funding flexibility for redevelopment projects [5]. - Extendicare is advancing 18 redevelopment projects to align with the new funding program [5]. Financial Position - As of June 30, 2025, Extendicare had cash and cash equivalents of $72.6 million, with access to an additional $152.2 million under its revolving facility [25]. - The company increased its senior secured credit facility to $375.0 million, enhancing its liquidity position [3][8]. Dividend Declaration - The Board of Directors declared a cash dividend of $0.042 per share for August 2025, payable on September 15, 2025 [30].